eNOS and stroke: Prevention, treatment and recovery

Future Neurology

Volumn 3, Issue 5, 2008, Pages 537-550

  Gertz, Karen ^a   Endres, Matthias ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endothelial nitric; Ischemic; Nitric oxide; Oxide synthase; Stroke

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERLEUKIN 8; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; COLLATERAL CIRCULATION; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HYPERTENSION; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; THROMBOCYTE FUNCTION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 55649090046     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/14796708.3.5.537     Document Type: Review

References (146)

1. Truelsen T, Piechowski-Jozwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G: Stroke incidence and prevalence in Europe: a review of available data. Eur. J. Neurol. 13, 581-598 (2006).
2. Kolominsky-Rabas PL, Heuschmann PU, Marschall D et al.: Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 37, 1179-1183 (2006).
3. Asplund K, Tuomilehto J, Stegmayr B, Wester PO, Tunstall-Pedoe H: Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med. Stand. Suppl. 728, 26-39 (1988).
4. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397 (1999).
5. Dirnagl U: Bench to bedside: the quest for quality in experimental stroke research. J. Cereb. Blood Flow Metab. 26, 1465-1478 (2006).
6. Martínez-Sánchez P, Díez-Tejedor E, Fuentes B, Ortega-Casarrubios MA, Hacke W: Systemic reperfusion therapy in acute ischemic stroke. Cerebrovasc. Dis. 24, 143-152 (2007).
7. Diener HC: Antiplatelet agents and randomized trials. Rev. Neurol. Dis. 4, 177-183 (2007).
8. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376 (1980).
9. Feelisch M, te Poel M, Zamora R, Deussen A, Moncada S: Understanding the controversy over the identity of EDRF. Nature 368, 62-65 (1994).
10. Lundberg JO, Weitzberg E, Gladwin MT: The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7, 156-167 (2008).
11. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770 (1990).
12. Chen J, Petranka J, Yamamura K, London RE, Steenbergen C, Murphy E: Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. Am. J. Physiol. Heart Circ. Physiol. 285, H2657-H2662 (2003).
13. Ward ME, Toporsian M, Scott JA et al.: Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. J. Clin. Invest. 115, 3128-3139 (2005).
14. Murphy S, Simmons ML, Agullo L et al.: Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16, 323-328 (1993).
15. Pollock JS, Forstermann U, Mitchell JA et al.: Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endotheial cells. Proc. Natl Acad Sci. USA 88, 10480-10484 (1991).
16. Carreras MC, Franco MC, Finocchietto PV et al.: The biological significance of mtNOS modulation. Front. Biosci. 12, 1041-1048 (2007).
17. Riobo NA, Melani M, Sanjuan N et al.: The modulation of mitochondrial nitric-oxide synthase activity in rat brain development. J. Biol. Chem. 277, 42447-42455 (2002).
18. Andrew PJ, Mayer B: Enzymatic function of nitric oxide synthases. Cardiovasc. Res. 43, 521-531 (1999).
19. Galea E, Feinstein DL, Reis DJ: Induction of calcium in-dependent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl Acad. Sci. USA 89, 10945-10949 (1992).
20. Zhang R, Min W, Sessa WC: Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J. Biol. Chem. 270, 15320-15326 (1995).
21. Laufs U, Endres M, Custodis F et al.: Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102, 3104-3110 (2000).
22. García-Gardena G, Fan R, Shah V et al.: Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 292, 821-824 (1998).
23. Fulton D, Fontana J, Sowa G et al.: Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J. Biol. Chem. 277, 4277-4284 (2002).
24. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605 (1999).
25. Boo YC, Sorescu G, Boyd N et al.: Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J. Biol. Chem. 277, 3388-3396 (2002).
26. Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM: Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 22(7), 2185-2197 (2008).
27. Blanes MG, Oubaha M, Rautureau Y, Gratton JP: Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells. J. Biol. Chem. 282, 10660-10669 (2007).
28. Dudzinski DM, Michel T: Life history of eNOS: partners and pathways. Cardiovasc. Res. 75, 247-260 (2007).
29. Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424 (2007).
30. Li H, Wallerath T, Münzel T, Förstermann U: Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7, 149-164 (2002).
31. Landmesser U, Dikalov S, Price SR et al.: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209 (2003).
32. Cheng J, Ou JS, Singh H et al.: 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 294, H1018-H1026 (2008).
33. Zhang ZG, Chopp M, Zaloga C, Pollock JS, Förstermann U: Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 24, 2016-2021 (1993).
34. Morikawa E, Moskowitz MA, Huang Z, Yoshida T, Irikura K, Dalkara T: L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25, 429-435 (1994).
35. Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, Endres M: Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res. 942, 23-30 (2002).
36. Ando H, Zhou J, Macova M, Imboden H, Saavedra JM: Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 35, 1726-1731 (2004).
37. Mason RP, Kubant R, Heeba G et al.: Synergistic efect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction. Pharm. Res. 25(8), 1798-1806 (2007).
38. Szolnoki Z, Havasi V, Bene J et al.: Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. Acta Neurol. Stand. 111, 29-33 (2005).
39. Dutra AV, Lin HF, Juo SH et al.: Analysis of the endothelial nitric oxide synthase gene as a modifier of the cerebral response to ischemia. J. Stroke Cerebrovasc. Dis. 15, 128-131 (2006).
40. Andresen J, Shafi NI, Bryan RM Jr: Endothelial influences on cerebrovascular tone. J. Appl. Physiol. 100, 318-327 (2006).
41. Huang PL, Huang Z, Mashimo H et al.: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242 (1995).
42. Zhang F, White JG, Iadecola C: Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J. Cereb. Blood Flow Metab. 14, 217-226 (1994).
43. Endres M, Laufs U, Huang Z et al.: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 95, 8880-8885 (1998).
44. O'Regan C, Wu P, Arora P, Perri D, Mills EJ: Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am. J. Med. 121, 24-33 (2008).
45. Heart Protection Study Collaborative Group: Mrc/bhf heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7-22 (2002).
46. ASCOT investigators: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361, 1149-1158 (2003).
47. Lee CD, Folsom AR, Blair SN: Physical activity and stroke risk: a meta-analysis. Stroke 34, 2475-2481 (2003).
48. Endres M, Gertz K, Lindauer U et al.: Mechanisms of stroke protection by physical activity. Ann. Neurol. 54, 582-590 (2003).
49. Gertz K, Priller J, Kronenberg G et al.: Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ. Res. 99, 1132-1140 (2006).
50. Harris RA, Padilla J, Hanlon KP, Rink LD, Wallace JP: The flow-mediated dilation response to acute exercise in overweight active and inactive men. Obesity (Silver Spring) 16, 578-584 (2008).
51. Loufrani L, Retailleau K, Bocquet A et al.: Key role of the α1-β1 integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 294(4), H1906-H1913 (2008).
52. Jin ZG, Wong C, Wu J, Berk BC: Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells. J. Biol. Chem. 280, 12305-12309 (2005).
53. Saavedra JM, Benicky J, Zhou J: Mechanisms of the anti-ischemic effect of angiotensin II AT (1) receptor antagonists in the brain. Cell Mol. Neurobiol. 26, 1099-1111 (2006).
54. Patel AB, Kostis JB, Wilson AC, Shea ML, Pressel SL, Davis BR: Long-term fatal outcomes in subjects with stroke or transient ischemic attack. Fourteen-year follow-up of the systolic hypertension in the elderly program. Stroke 39(4), 1084-1089 (2008).
55. Kimoto-Kinoshita S, Nishida S, Tomura TT: Decrease of endothelial nitric oxide synthase in stroke-prone spontaneously hypertensive rat cerebral cortex. Neurosci. Lett. 288, 103-106 (2000).
56. Yamakawa H, Jezova M, Ando H Saavedra JM: Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J. Cereb. Blood Flow Metab. 23, 371-380 (2003).
57. Nishimura Y, Ito T, Saavedra JM: Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31, 2478-2486 (2000).
58. Blakeley JO, Llinas RH: Thrombolytic therapy for acute ischemic stroke. J. Neurol. Sci. 261, 55-62 (2007).
59. Freedman JE, Ting B, Hankin B, Loscalzo J, Keaney JF Jr, Vita JA: Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation 98, 1481-1486 (1998).
60. Shimasaki Y, Saito Y, Yoshimura M et al.: The effects of long-term smoking on endothelial nitric oxide synthase mRNA expression in human platelets as detected with real-time quantitative RT-PCR. Clin. Appl. Thromb. Hemost. 13, 43-51 (2007).
61. Ozüyaman B, Gödecke A, Küsters S, Kirchhoff E, Scharf RE, Schrader J: Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thromb. Haemost. 93, 1161-1167 (2005).
62. Iafrati MD, Vitseva O, Tanriverdi K et al.: Compensatory mechanisms influence hemostasis in setting of eNOS deficiency. Am. J. Physiol. Heart Circ. Physiol. 288, H1627-H1632 (2005).
63. Laufs U, Gertz K, Huang P et al.: Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31, 2442-2449 (2000).
64. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD: Nitric oxide released from activated platelets inhibits platelet recruitment. J. Clin. Invest. 100, 350-356 (1997).
65. Celi A, Pellegrini G, Lorenzet R et al.: P-selectin induces the expression of tissue factor on monocytes. Proc. Natl Acad. Sci. USA 91, 8767-8771 (1994).
66. Zerr-Fouineau M, Chataigneau M, Blot C, Schini-Kerth VB: Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors. FASEB J. 21, 265-273 (2007).
67. Kader KN, Akella R, Ziats NP et al.: eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro. Tissue Eng. 6, 241-251 (2000).
68. Lindenblatt N, Menger MD, Klar E, Vollmar B: Darbepoetin-α does not promote microvascular thrombus formation in mice: role of eNOS-dependent protection through platelet and endothelial cell deactivation. Arterioscler. Thromb. Vasc. Biol. 27, 1191-1198 (2007).
69. Stamler J, Mendelsohn ME, Amarante P et al.: N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res. 65, 789-795 (1989).
70. Riba R, Oberprieler NG, Roberts W, Naseem KM: Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism. J. Thromb. Haemost. 4, 2636-2644 (2006).
71. Igarashi J, Miyoshi M, Hashimoto T, Kubota Y, Kosaka H: Hydrogen peroxide induces S1P1 receptors and sensitizes vascular endothelial cells to sphingosine 1-phosphate, a platelet-derived lipid mediator. Am. J. Physiol. Cell Physiol. 292, C740-C748 (2007).
72. Stagliano NE, Dietrich WD, Prado R, Green EJ, Busto R: The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat. Brain Res. 759, 32-40 (1997).
73. Gertz K, Laufs U, Lindauer U et al.: Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34, 551-557 (2003).
74. Liu L, Zhao SP, Zhou HN, Li QZ, Li JX: Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension. J. Cardiovasc. Pharmacol. 50, 50-55 (2007).
75. Asahi M, Huang Z, Thomas S et al.: Protective effects of stains involving both eNOS and tPA in fiscal cerebral ischemia. J. Cereb. Blood Flow Metab. 25, 722-729 (2005).
76. Kriz J: Inflammation in ischemic brain injury: timing is important. Crit. Rev. Neurobiol. 18, 145-157 (2006).
77. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J: Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin. Sci. (Lond.) 111, 171-183 (2006).
78. Kofler S, Nickel T, Weis M: Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin. Sci. (Lond.) 108, 205-213 (2005).
79. Kaushal V, Schlichter LC: Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 28, 2221-2230 (2008).
80. Mander P, Borutaite V, Moncada S, Brown GC: Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J. Neurosci. Res. 79, 208-215 (2005).
81. McColl BW, Rothwell NJ, Allan SM: Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 27, 4403-4412 (2007).
82. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV: Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38, 1345-1353 (2007).
83. Martinez-Revelles S, Jimenez-Altayo F, Caracuel L, Perez-Asensio FJ, Planas AM, Vila E: Endothelial dysfunction in rat mesenteric resistance artery after transient middle cerebral artery occlusion. J. Pharmacol. Exp. Ther. 325, 363-369 (2008).
84. Prass K, Meisel C, Höflich C et al.:: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198, 725-736 (2003).
85. Lalancette-Hébert M, Gowing G, Simard A, Weng YC, Kriz J: Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596-2605 (2007).
86. Ying L, Hofseth LJ: An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 67, 1407-1410 (2007).
87. Depino A, Ferrari C, Pott Godoy MC, Tarelli R, Pitossi FJ. Differential effects of interleukin-1β on neurotoxicity, cytokine induction and glial reaction in specific brain regions. J. Neuroimmunol. 168, 96-110 (2005).
88. Tanaka T, Kanai H, Sekiguchi K et al.: Induction of VEGF gene transcription by IL-1 β is mediated through stress-activated MAP kinases and Spl sites in cardiac myocytes. J. Mol. Cell. Cardiol. 32, 1955-1967 (2000).
89. Charalambous C, Pen LB, Su YS, Milan J, Chen TC, Hofman FM: Interleukin-8 differentially regulates migration of tumour-associated and normal human brain endothelial cells. Cancer Res. 65, 10347-10354 (2005).
90. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE: Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167, 1644-1653 (2001).
91. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376, 517 (1995).
92. 2 and tumor necrosis factor α on the VEGF-receptor system expression in cultured porcine luteal cells. Mol. Reprod. Dev. DOI: 10.1002/mrd.20897 (2008).
93. Borg SA, Kerry KE, Royds JA, Battersby RD, Jones TH: Correlation of VEGF production with IL1-α and IL6 secretion by human pituitary adenoma cells. Eur. J. Endocrinol. 152, 293-300 (2005).
94. Vallance BA, Dijkstra G, Qiu B et al.: Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G865-G874 (2004).
95. Conelly L, Jacobs AT, Palacios-Callender M, Moncada S, Hobbs AJ: Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J. Biol. Chem. 278, 26480-26487 (2003).
96. Kaminski A, Pohl CB, Sponholz C et al.: Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice. Am. J. Pathol. 164, 2241-2249 (2004).
97. Grumbach IM, Chen W, Mertens SA, Harrison DG: A negative feedback mechanism involving nitric oxide and nudest factor κ-B modulates endothelial nitric oxide synthase transcription. J. Mol. Cell. Cardiol. 39, 595-603 (2005).
98. Fernández-Hernando C, Ackah E, Yu J et al.: Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 6, 446-457 (2007).
99. Sukhanov S, Higashi Y, Shai SY et al.: IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 2684-2690 (2007).
100. Jantzen F, Könemann S, Wolff B et al.: Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. J. Physiol. Pharmacol. 58, 503-514 (2007).
101. Palmer TD, Willhoite AR, Gage FH: Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 425, 479-494 (2000).
102. Risau W: Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
103. Hayashi T, Deguchi K, Nagotani S et al.: Cerebral ischemia and angiogenesis. Curr. Neurovasc. Res. 3, 119-129 (2006).
104. Lee SR, Lo FH: Induction of caspase-mediated cell death by matrix metalloptoteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 24, 720-727 (2004).
105. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J: Serial measurement of vascular endothelial growth factor and transforming growth factor-β1 in serum of patients with acute ischemic stroke. Stroke 31, 1863-1870 (2000).
106. Renner O, Tsimpas A, Kostin S et al.: Time- and cell type-specific induction of platelet-derived growth factor receptor-β during cerebral ischemia. Brain Res. Mol. Brain Res. 113, 44-51 (2003).
107. Issa R, AlQteishat A, Mitsios N et al.: Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 8, 53-62 (2005).
108. Dimaio TA, Wang S, Huang Q, Scheef EA, Sorenson CM, Sheibani N: Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev. Biol. 315, 72-88 (2008).
109. Rask-Madsen C, King GL: Differential regulation of VEGF signaling by PKCα and PKCvaṙin endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 919-924 (2008).
110. Murohara T, Asahara T, Silver M et al.: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101, 2567-2578 (1998).
111. Edirisinghe I, Yang SR, Yao H et al.: VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J. 22(7), 2297-2310 (2008).
112. Greenberg DA, Jin K: From angiogenesis to neuropathology. Nature 438, 954-959 (2005).
113. Schoch HJ, Fischer S, Marti HH: Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125, 2549-2557 (2002).
114. Valable S, Montaner J, Bellail A et al.: VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia both effects decreased by Ang-1. J. Cereb. Blood Flow Metab. 25, 1491-1504 (2005).
115. Kaya D, Gursoy-Ozdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T: VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J. Cereb. Blood Flow Metab. 25, 1111-1118 (2005).
116. Zhang ZG, Zhang L, Jiang Q et al.: VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838 (2000).
117. Li L, Hisamoto K, Kim KH et al.: Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc. Natl Acad Sci. USA 104, 16468-16473 (2007).
118. Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, Stewart DJ: Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am. J. Pathol. 162, 1927-1936 (2003).
119. Urano T, Ito Y, Akao M et al.: Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2- eNOS-NO pathway in a mouse hind-limb ischemia model. Arterioscler. Thromb. Vasc. Biol. 28, 827-834 (2008).
120. D'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS: Essential role of endothelial nitric oxide synthase in vascular effects of erythropoitin. Hypertension 49, 1142-1148 (2007).
121. Kashiwagi S, Izumi Y, Gohongi T et al.: NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J. Clin. Invest. 115, 1816-1827 (2005).
122. Kokovay E, Li L, Cunningham LA: Angiogenic recruitment of pericytes from bone marrow after stroke. J. Cereb. Blood Flow Metab. 26, 545-555 (2006).
123. Renner O, Tsimpas A, Kostin S et al.: Time- and cell type-specific induction of platelet-derived growth factor receptor-β during cerebral ischemia. Brain Res. Mol. Brain Res. 113, 44-51 (2003).
124. Aicher A, Heeschen C, Mildner-Rihm C et al.: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9, 1370-1376 (2003).
125. Sasaki K, Heeschen C, Aicher A et al.: Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl Acad. Sci. USA 103, 14537-14541 (2006).
126. + bone marrow stem cells. Lab. Invest. 88, 58-69 (2008).
127. Chen J, Zhang C, Jiang H et al.: Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J. Cereb. Blood Flow Metab. 25, 281-290 (2005).
128. Wiltrout C, Lang B, Yan Y, Dempsey RJ, Vemuganti R: Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem. Int. 50, 1028-1041 (2007).
129. Quiñones-Hinojosa A, Sanai N, Soriano-Navarro M et al.: Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J. Comp. Neurol. 494, 415-434 (2006).
130. Gage FH, Kempermann G, Palmer TD, Peterson DA, Ray J: Multipotent progenitor cells in the adult dentate gyrus. J. Neurobiol. 36, 249-266 (1998).
131. Kornack DR, Rakic P: Cell proliferation without neurogenesis in adult primate neocortex. Science 294, 2127-2130 (2001).
132. Gould E, Reeves AJ, Graziano MS, Gross CG: Neurogenesis in the neocortex of adult primates. Science 286, 548-552 (1999).
133. Seri B, García-Verdugo JM, Collado-Morente L, McEwen BS, Alvarez-Buylla A: Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus. J. Comp. Neurol. 478, 359-378 (2004).
134. Arvidsson A, Kokaia Z, Lindvall O: N-methyl-D-aspartate receptor mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur. J. Neurosci. 14, 10-18 (2001).
135. Takasawa K, Kitagawa K, Yagita Y et al.: Increased proliferation of neural progenitor cells but reduced survival of newborn cells in the contralateral hippocampus after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 22, 299-307 (2002).
136. Yan YP, Sailor KA, Vemuganti R, Dempsey RJ: Insulin-like growth factor-1 is an endogenous mediator of focal ischemia-induced neural progenitor proliferation. Eur. J. Neurosci. 24, 45-54 (2006).
137. Luo CX, Zhu XJ, Zhang AX et al.: Blockade of L-type voltage-gated Ca channel inhibits ischemia-induced neurogenesis by down-regulating iNOS expression in adult mouse. J. Neurochem. 94, 1077-1086 (2005).
138. Sun Y, Jin K, Childs JT, Xie L, Mao XO, Greenberg DA: Neuronal nitric oxide synthase and ischemia-induced neurogenesis. J. Cereb. Blood Flow Metab. 25, 485-492 (2005).
139. Zhang P, Liu Y, Li J et al.: Decreased neuronal nitric oxide synthase expression and cell migration in the peri-infarction after focal cerebral ischemia in rats. Neuropathology 27, 347-354 (2007).
140. Chen J, Zacharek A, Zhang C et al.: Endothelial nitric oxide synthase regulates brain derived neurotrophic factor expression. and neurogenesis after stroke in mice. J. Neurosci. 25, 2366-2375 (2005).
141. Zhang R, Zhang L, Zhang Z et al.: A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann. Neurol. 50, 602-611 (2001).
142. Zhang R, Zhang Z, Zhang L, Wang Y, Zhang C, Chopp M: Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J. Neurosci. Res. 83, 1213-1219 (2006).
143. Wang Y, Jin K, Mao XO et al.: VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J. Neurosci. Res. 85, 740-747 (2007).
144. Reif A, Schmitt A, Fritzen S et al.: Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur. J. Neurosci. 20, 885-895 (2004).
145. Ohab JJ, Fleming S, Blesch A, Carmichael ST: A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26, 13007-13016 (2006).
146. Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z, Lindvall O: Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 38, 3032-3039 (2007).